Review



shctrl f 5  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc shctrl f 5
    Shctrl F 5, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 19 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shctrl+3/pLKO%2E1+shControl+(Plasmid+%2374972)/pm39657676-812-9-57
    Average 93 stars, based on 19 article reviews
    shctrl f 5 - by Bioz Stars, 2026-11
    93/100 stars

    Images

    Related Articles

    Plasmid Preparation:

    Article Title: LncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell cycle progression in cancer
    Article Snippet: Total RNA was isolated from cultured cells using an RNeasy Mini kit (Qiagen, #74104) according to the manufacturer’s instructions. .. Then, 3 μg of pLKO.1 shControl (shCtrl) or pLKO.1 sh EPIC1 plasmid, 2.25 μg of psPAX2 (Addgene, #12260), and 0.75 μg of pVSV-G (Addgene, #8454) were used for each 6-cm petri dish. ..

    Article Title: GPS2 promotes erythroid differentiation in K562 erythroleukemia cells primarily via NCOR1.
    Article Snippet: G protein pathway suppressor 2 (GPS2) has been shown to play a pivotal role in human and mouse definitive erythropoiesis in an EKLF-dependent manner.. However, whether GPS2 affects human primitive erythropoiesis is still unknown.. This study demonstrated that GPS2 positively regulates erythroid differentiation in K562 cells, which have a primitive erythroid phenotype.

    Article Title: CAMSAP2 localizes to the Golgi in islet β-cells and facilitates Golgi-ER trafficking
    Article Snippet: The CAMSAP2-targeting shRNA (shCAM) no #1 [TRCN0000252418, 5′-TTGTCCGGCTAGAGGATATTT-3'] and no #2 [TRCN0000252419, 5′-AGTTTCTCTGTCCGATTTAAA-3'] are in the plasmid pLKO.1-CMV-tGFP and are from MilliporeSigma. .. The non-targeting shRNA control (shCtrl) [5′-CCTAAGGTTAAGTCGCCCTCGCTC-3′] plasmid, pLKO.1-shCtrl-puro, is from Addgene (cat. # 1864). ..

    Article Title: Targeting cancer-associated long non-coding RNAs
    Article Snippet: .. Then, 3 mg of pLKO.1 shControl (shCtrl) or pLK0.1 shEPIC1 plasmid, 2.25 mg of psPAX2 (Addgene, #12260), and 0.75 mg of pVSV-G (Addgene, #8454) were used for each 6-cm petri dish. ..

    other:

    Article Title: CAMSAP2 localizes to the Golgi in islet β-cells and facilitates Golgi-ER trafficking
    Article Snippet: shCtrl 5′-CCTAAGGTTAAGTCGCCCTCGCTC-3′] , Addgene , 1864.

    Article Title: USP13 stabilizes NLRP3 to facilitate inflammasome activation by preventing TRIM31-mediated NLRP3 ubiquitination and degradation
    Article Snippet: Flag-human USP13, HA-human TRIM31, GFP-human TRIM31, and GFP-human FBXL2 plasmids were purchased from Hunan Fenghui Biotechnology Co., Ltd. HA-ubiquitin, HA-ubiquitin K48-only (all lysines mutated to arginine except K48; forms only K48-linked chains), and HA-ubiquitin K63-only (all lysines mutated to arginine except K63; forms only K63-linked chains) plasmids were a gift from X.-M. Zhang (National Center of Biomedical Analysis, Beijing, China).

    shRNA:

    Article Title: GPS2 promotes erythroid differentiation in K562 erythroleukemia cells primarily via NCOR1.
    Article Snippet: G protein pathway suppressor 2 (GPS2) has been shown to play a pivotal role in human and mouse definitive erythropoiesis in an EKLF-dependent manner.. However, whether GPS2 affects human primitive erythropoiesis is still unknown.. This study demonstrated that GPS2 positively regulates erythroid differentiation in K562 cells, which have a primitive erythroid phenotype.

    Article Title: CAMSAP2 localizes to the Golgi in islet β-cells and facilitates Golgi-ER trafficking
    Article Snippet: The CAMSAP2-targeting shRNA (shCAM) no #1 [TRCN0000252418, 5′-TTGTCCGGCTAGAGGATATTT-3'] and no #2 [TRCN0000252419, 5′-AGTTTCTCTGTCCGATTTAAA-3'] are in the plasmid pLKO.1-CMV-tGFP and are from MilliporeSigma. .. The non-targeting shRNA control (shCtrl) [5′-CCTAAGGTTAAGTCGCCCTCGCTC-3′] plasmid, pLKO.1-shCtrl-puro, is from Addgene (cat. # 1864). ..

    Control:

    Article Title: GPS2 promotes erythroid differentiation in K562 erythroleukemia cells primarily via NCOR1.
    Article Snippet: G protein pathway suppressor 2 (GPS2) has been shown to play a pivotal role in human and mouse definitive erythropoiesis in an EKLF-dependent manner.. However, whether GPS2 affects human primitive erythropoiesis is still unknown.. This study demonstrated that GPS2 positively regulates erythroid differentiation in K562 cells, which have a primitive erythroid phenotype.

    Article Title: CAMSAP2 localizes to the Golgi in islet β-cells and facilitates Golgi-ER trafficking
    Article Snippet: The CAMSAP2-targeting shRNA (shCAM) no #1 [TRCN0000252418, 5′-TTGTCCGGCTAGAGGATATTT-3'] and no #2 [TRCN0000252419, 5′-AGTTTCTCTGTCCGATTTAAA-3'] are in the plasmid pLKO.1-CMV-tGFP and are from MilliporeSigma. .. The non-targeting shRNA control (shCtrl) [5′-CCTAAGGTTAAGTCGCCCTCGCTC-3′] plasmid, pLKO.1-shCtrl-puro, is from Addgene (cat. # 1864). ..

    Countercurrent Chromatography:

    Article Title: GPS2 promotes erythroid differentiation in K562 erythroleukemia cells primarily via NCOR1.
    Article Snippet: G protein pathway suppressor 2 (GPS2) has been shown to play a pivotal role in human and mouse definitive erythropoiesis in an EKLF-dependent manner.. However, whether GPS2 affects human primitive erythropoiesis is still unknown.. This study demonstrated that GPS2 positively regulates erythroid differentiation in K562 cells, which have a primitive erythroid phenotype.

    Clone Assay:

    Article Title: GPS2 promotes erythroid differentiation in K562 erythroleukemia cells primarily via NCOR1.
    Article Snippet: G protein pathway suppressor 2 (GPS2) has been shown to play a pivotal role in human and mouse definitive erythropoiesis in an EKLF-dependent manner.. However, whether GPS2 affects human primitive erythropoiesis is still unknown.. This study demonstrated that GPS2 positively regulates erythroid differentiation in K562 cells, which have a primitive erythroid phenotype.

    Sequencing:

    Article Title: USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities
    Article Snippet: pRK5-HA-Ubiquitin-WT , Gift from Ted Dawson , RRID: Addgene_17608. .. pLKO.1-shCtrl-Puro Target sequence: 5′-CCTAAGGTTAAGTCGCCCTCG-3′ , Addgene , RRID: Addgene_136035. .. pLKO.1-shUSP9X_1-Puro Target sequence: 5′-GAGAGTTTATTCACTGTCTTA-3′ , Sigma-Aldrich , TRCN0000007361.



    Similar Products

    93
    Addgene inc shctrl f 5
    Shctrl F 5, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shctrl+3/pLKO%2E1+shControl+(Plasmid+%2374972)/pm39657676-812-9-57
    Average 93 stars, based on 1 article reviews
    shctrl f 5 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    90
    GemPharmatech Co Ltd shctrl 3/4
    Inhibiting NTRs in MB cells affects the in vitro sphere‐forming ability and in vivo tumorigenic capacity. A,B) Extreme limiting dilution assays (ELDAs) were conducted to assess the ability of cells to form colonies, demonstrating a decrease in neurosphere frequency upon NTR inhibition in Group 3 (HTB‐187) or Group 3/4 (HTB‐185) cells. HTB‐185 and HTB‐187 cells were seeded in 24‐well ultra‐low attachment plates at various concentrations, including 100, 50, 25, 10, and 5 cells per well. Each sphere‐forming well was counted and the dilution ratio was plotted based on the number of diluted cells and the number of sphere‐forming wells. **** P < 0.0001. C) Display of representative spheres derived from Group 3 or Group 3/4 cells expressing either control shRNA <t>(shCtrl),</t> shHTR2C, or shGABRG2. Images of colonies were captured after 1 week of incubation. D,E) Relative HTR2C or GABRG2 expression was measured by qRT‐PCR in shCtrl, shHTR2C, and shGABRG2 Group3/4 cells. Data are shown as the mean ± SEM. ** P < 0.01. F) left, HE staining of the maximum cross‐sectional area of G3/4 intracranial orthotopic xenograft model among each group. G) Statistical results of the percentage of medulloblastoma tumor size divide the whole section. Data are expressed as dots. ** P < 0.01. H) Immunofluorescence staining of GFAP, IBA1, NeuN revealed less GFAP and increased IBA1 signal in shHTR2C and shGABRG2 groups. Shown are representative images from at least three mice with similar results. I,J) Quantification of GFAP and IBA1 of each group described in H. * P < 0.05, ** P < 0.01, **** P < 0.0001. (Scale bars: 50 µm in C, 2 mm in F, 100 µm in H).
    Shctrl 3/4, supplied by GemPharmatech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shctrl+3/shctrl+3+4/pmc11321678-388-8-28
    Average 90 stars, based on 1 article reviews
    shctrl 3/4 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    GemPharmatech Co Ltd shhtr2c, shgabrg2, and shctrl 3/4 cells
    Inhibiting NTRs in MB cells affects the in vitro sphere‐forming ability and in vivo tumorigenic capacity. A,B) Extreme limiting dilution assays (ELDAs) were conducted to assess the ability of cells to form colonies, demonstrating a decrease in neurosphere frequency upon NTR inhibition in Group 3 (HTB‐187) or Group 3/4 (HTB‐185) cells. HTB‐185 and HTB‐187 cells were seeded in 24‐well ultra‐low attachment plates at various concentrations, including 100, 50, 25, 10, and 5 cells per well. Each sphere‐forming well was counted and the dilution ratio was plotted based on the number of diluted cells and the number of sphere‐forming wells. **** P < 0.0001. C) Display of representative spheres derived from Group 3 or Group 3/4 cells expressing either control shRNA <t>(shCtrl),</t> shHTR2C, or shGABRG2. Images of colonies were captured after 1 week of incubation. D,E) Relative HTR2C or GABRG2 expression was measured by qRT‐PCR in shCtrl, shHTR2C, and shGABRG2 Group3/4 cells. Data are shown as the mean ± SEM. ** P < 0.01. F) left, HE staining of the maximum cross‐sectional area of G3/4 intracranial orthotopic xenograft model among each group. G) Statistical results of the percentage of medulloblastoma tumor size divide the whole section. Data are expressed as dots. ** P < 0.01. H) Immunofluorescence staining of GFAP, IBA1, NeuN revealed less GFAP and increased IBA1 signal in shHTR2C and shGABRG2 groups. Shown are representative images from at least three mice with similar results. I,J) Quantification of GFAP and IBA1 of each group described in H. * P < 0.05, ** P < 0.01, **** P < 0.0001. (Scale bars: 50 µm in C, 2 mm in F, 100 µm in H).
    Shhtr2c, Shgabrg2, And Shctrl 3/4 Cells, supplied by GemPharmatech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shctrl+3/shhtr2c++shgabrg2++and+shctrl+3+4+cells/pm38884167-504-3-27
    Average 90 stars, based on 1 article reviews
    shhtr2c, shgabrg2, and shctrl 3/4 cells - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    VectorBuilder GmbH shrnas targeting rosa26 (shctrl) and the 3'-untranslated region (3'-utr) of thoc1, stau1, serbp1, and skiv2l
    Inhibiting NTRs in MB cells affects the in vitro sphere‐forming ability and in vivo tumorigenic capacity. A,B) Extreme limiting dilution assays (ELDAs) were conducted to assess the ability of cells to form colonies, demonstrating a decrease in neurosphere frequency upon NTR inhibition in Group 3 (HTB‐187) or Group 3/4 (HTB‐185) cells. HTB‐185 and HTB‐187 cells were seeded in 24‐well ultra‐low attachment plates at various concentrations, including 100, 50, 25, 10, and 5 cells per well. Each sphere‐forming well was counted and the dilution ratio was plotted based on the number of diluted cells and the number of sphere‐forming wells. **** P < 0.0001. C) Display of representative spheres derived from Group 3 or Group 3/4 cells expressing either control shRNA <t>(shCtrl),</t> shHTR2C, or shGABRG2. Images of colonies were captured after 1 week of incubation. D,E) Relative HTR2C or GABRG2 expression was measured by qRT‐PCR in shCtrl, shHTR2C, and shGABRG2 Group3/4 cells. Data are shown as the mean ± SEM. ** P < 0.01. F) left, HE staining of the maximum cross‐sectional area of G3/4 intracranial orthotopic xenograft model among each group. G) Statistical results of the percentage of medulloblastoma tumor size divide the whole section. Data are expressed as dots. ** P < 0.01. H) Immunofluorescence staining of GFAP, IBA1, NeuN revealed less GFAP and increased IBA1 signal in shHTR2C and shGABRG2 groups. Shown are representative images from at least three mice with similar results. I,J) Quantification of GFAP and IBA1 of each group described in H. * P < 0.05, ** P < 0.01, **** P < 0.0001. (Scale bars: 50 µm in C, 2 mm in F, 100 µm in H).
    Shrnas Targeting Rosa26 (Shctrl) And The 3' Untranslated Region (3' Utr) Of Thoc1, Stau1, Serbp1, And Skiv2l, supplied by VectorBuilder GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shctrl+3/shrnas+targeting+rosa26++shctrl/10__1172_slash_jci163325-320-17-26
    Average 90 stars, based on 1 article reviews
    shrnas targeting rosa26 (shctrl) and the 3'-untranslated region (3'-utr) of thoc1, stau1, serbp1, and skiv2l - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    95
    Addgene inc plko 1 shctrl puro target sequence 5 cctaaggttaagtcgccctcg 3
    Inhibiting NTRs in MB cells affects the in vitro sphere‐forming ability and in vivo tumorigenic capacity. A,B) Extreme limiting dilution assays (ELDAs) were conducted to assess the ability of cells to form colonies, demonstrating a decrease in neurosphere frequency upon NTR inhibition in Group 3 (HTB‐187) or Group 3/4 (HTB‐185) cells. HTB‐185 and HTB‐187 cells were seeded in 24‐well ultra‐low attachment plates at various concentrations, including 100, 50, 25, 10, and 5 cells per well. Each sphere‐forming well was counted and the dilution ratio was plotted based on the number of diluted cells and the number of sphere‐forming wells. **** P < 0.0001. C) Display of representative spheres derived from Group 3 or Group 3/4 cells expressing either control shRNA <t>(shCtrl),</t> shHTR2C, or shGABRG2. Images of colonies were captured after 1 week of incubation. D,E) Relative HTR2C or GABRG2 expression was measured by qRT‐PCR in shCtrl, shHTR2C, and shGABRG2 Group3/4 cells. Data are shown as the mean ± SEM. ** P < 0.01. F) left, HE staining of the maximum cross‐sectional area of G3/4 intracranial orthotopic xenograft model among each group. G) Statistical results of the percentage of medulloblastoma tumor size divide the whole section. Data are expressed as dots. ** P < 0.01. H) Immunofluorescence staining of GFAP, IBA1, NeuN revealed less GFAP and increased IBA1 signal in shHTR2C and shGABRG2 groups. Shown are representative images from at least three mice with similar results. I,J) Quantification of GFAP and IBA1 of each group described in H. * P < 0.05, ** P < 0.01, **** P < 0.0001. (Scale bars: 50 µm in C, 2 mm in F, 100 µm in H).
    Plko 1 Shctrl Puro Target Sequence 5 Cctaaggttaagtcgccctcg 3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shctrl+3/PLKO%2E1-Scrambled+(Plasmid+%23136035)/pmc10140597-109-0-5
    Average 95 stars, based on 1 article reviews
    plko 1 shctrl puro target sequence 5 cctaaggttaagtcgccctcg 3 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    90
    Addgene inc shctrl 5’-cctaaggttaagtcgccctcgctc-3
    Inhibiting NTRs in MB cells affects the in vitro sphere‐forming ability and in vivo tumorigenic capacity. A,B) Extreme limiting dilution assays (ELDAs) were conducted to assess the ability of cells to form colonies, demonstrating a decrease in neurosphere frequency upon NTR inhibition in Group 3 (HTB‐187) or Group 3/4 (HTB‐185) cells. HTB‐185 and HTB‐187 cells were seeded in 24‐well ultra‐low attachment plates at various concentrations, including 100, 50, 25, 10, and 5 cells per well. Each sphere‐forming well was counted and the dilution ratio was plotted based on the number of diluted cells and the number of sphere‐forming wells. **** P < 0.0001. C) Display of representative spheres derived from Group 3 or Group 3/4 cells expressing either control shRNA <t>(shCtrl),</t> shHTR2C, or shGABRG2. Images of colonies were captured after 1 week of incubation. D,E) Relative HTR2C or GABRG2 expression was measured by qRT‐PCR in shCtrl, shHTR2C, and shGABRG2 Group3/4 cells. Data are shown as the mean ± SEM. ** P < 0.01. F) left, HE staining of the maximum cross‐sectional area of G3/4 intracranial orthotopic xenograft model among each group. G) Statistical results of the percentage of medulloblastoma tumor size divide the whole section. Data are expressed as dots. ** P < 0.01. H) Immunofluorescence staining of GFAP, IBA1, NeuN revealed less GFAP and increased IBA1 signal in shHTR2C and shGABRG2 groups. Shown are representative images from at least three mice with similar results. I,J) Quantification of GFAP and IBA1 of each group described in H. * P < 0.05, ** P < 0.01, **** P < 0.0001. (Scale bars: 50 µm in C, 2 mm in F, 100 µm in H).
    Shctrl 5’ Cctaaggttaagtcgccctcgctc 3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shctrl+3/shctrl+5%E2%80%99+cctaaggttaagtcgccctcgctc+3/pmc09883185-82-0-3
    Average 90 stars, based on 1 article reviews
    shctrl 5’-cctaaggttaagtcgccctcgctc-3 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Genechem egfr knockdown lentiviral vectors shctrl, shegfr-1, shegfr-2, shegfr-3
    Inhibiting NTRs in MB cells affects the in vitro sphere‐forming ability and in vivo tumorigenic capacity. A,B) Extreme limiting dilution assays (ELDAs) were conducted to assess the ability of cells to form colonies, demonstrating a decrease in neurosphere frequency upon NTR inhibition in Group 3 (HTB‐187) or Group 3/4 (HTB‐185) cells. HTB‐185 and HTB‐187 cells were seeded in 24‐well ultra‐low attachment plates at various concentrations, including 100, 50, 25, 10, and 5 cells per well. Each sphere‐forming well was counted and the dilution ratio was plotted based on the number of diluted cells and the number of sphere‐forming wells. **** P < 0.0001. C) Display of representative spheres derived from Group 3 or Group 3/4 cells expressing either control shRNA <t>(shCtrl),</t> shHTR2C, or shGABRG2. Images of colonies were captured after 1 week of incubation. D,E) Relative HTR2C or GABRG2 expression was measured by qRT‐PCR in shCtrl, shHTR2C, and shGABRG2 Group3/4 cells. Data are shown as the mean ± SEM. ** P < 0.01. F) left, HE staining of the maximum cross‐sectional area of G3/4 intracranial orthotopic xenograft model among each group. G) Statistical results of the percentage of medulloblastoma tumor size divide the whole section. Data are expressed as dots. ** P < 0.01. H) Immunofluorescence staining of GFAP, IBA1, NeuN revealed less GFAP and increased IBA1 signal in shHTR2C and shGABRG2 groups. Shown are representative images from at least three mice with similar results. I,J) Quantification of GFAP and IBA1 of each group described in H. * P < 0.05, ** P < 0.01, **** P < 0.0001. (Scale bars: 50 µm in C, 2 mm in F, 100 µm in H).
    Egfr Knockdown Lentiviral Vectors Shctrl, Shegfr 1, Shegfr 2, Shegfr 3, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shctrl+3/egfr+knockdown+lentiviral+vectors+shctrl++shegfr+1++shegfr+2++shegfr+3/pmc09132982-279-8-26
    Average 90 stars, based on 1 article reviews
    egfr knockdown lentiviral vectors shctrl, shegfr-1, shegfr-2, shegfr-3 - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Shanghai GenePharma shrna negative control (shctrl; cat. no. 131127cz; 5′-ttctccgaacgtgtcacgtttc-3′)
    Downregulation of Beclin-1 enhances apoptosis and reduces cell viability induced by bortezomib in NB4 cells. Cells were infected with lentiviruses expressing shRNAs (non-targeting control or Beclin-1). Puromycin-resistant cells were pooled after each infection. (A) Cells transfected with the control <t>shRNA</t> and shBeclin-1 were treated with or without bortezomib (20 nM) for 24 h, and the expression levels of cleaved caspase-3, cleaved PARP, Bcl-2, p62 and Beclin-1, and LC3-I to LC3-II conversion were determined by western blotting. (B) Ratio of Bcl-2 and β-actin expression levels. Data are presented as the mean ± standard deviation of three independent repeats. *P<0.05 and **P<0.01. (C) Ratio of LC3-II and β-actin expression levels. Data are presented as the mean ± standard deviation of three independent repeats. **P<0.01. (D) Cells transfected with the control shRNA and shBeclin-1 were treated with bortezomib (20 nM) for 0 and 24 h, and cell viability was assessed using a water-soluble tetrazolium salts-8 assay. Data are presented as the mean ± standard deviation of three independent repeats. ***P<0.001. shRNA/sh, short <t>hairpin</t> <t>RNA;</t> CTRL, control; PARP, poly(ADP-ribose) polymerase.
    Shrna Negative Control (Shctrl; Cat. No. 131127cz; 5′ Ttctccgaacgtgtcacgtttc 3′), supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shctrl+3/shrna+negative+control++shctrl++cat++no++131127cz++5++ttctccgaacgtgtcacgtttc+3++/pmc07751351-45-13-26
    Average 90 stars, based on 1 article reviews
    shrna negative control (shctrl; cat. no. 131127cz; 5′-ttctccgaacgtgtcacgtttc-3′) - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Genechem non-silencing control (shctrl, target sequence 5’–ttctccgaacgtgtcacgt–3)
    Downregulation of Beclin-1 enhances apoptosis and reduces cell viability induced by bortezomib in NB4 cells. Cells were infected with lentiviruses expressing shRNAs (non-targeting control or Beclin-1). Puromycin-resistant cells were pooled after each infection. (A) Cells transfected with the control <t>shRNA</t> and shBeclin-1 were treated with or without bortezomib (20 nM) for 24 h, and the expression levels of cleaved caspase-3, cleaved PARP, Bcl-2, p62 and Beclin-1, and LC3-I to LC3-II conversion were determined by western blotting. (B) Ratio of Bcl-2 and β-actin expression levels. Data are presented as the mean ± standard deviation of three independent repeats. *P<0.05 and **P<0.01. (C) Ratio of LC3-II and β-actin expression levels. Data are presented as the mean ± standard deviation of three independent repeats. **P<0.01. (D) Cells transfected with the control shRNA and shBeclin-1 were treated with bortezomib (20 nM) for 0 and 24 h, and cell viability was assessed using a water-soluble tetrazolium salts-8 assay. Data are presented as the mean ± standard deviation of three independent repeats. ***P<0.001. shRNA/sh, short <t>hairpin</t> <t>RNA;</t> CTRL, control; PARP, poly(ADP-ribose) polymerase.
    Non Silencing Control (Shctrl, Target Sequence 5’–Ttctccgaacgtgtcacgt–3), supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shctrl+3/non+silencing+control/pmc06991670-63-13-22
    Average 90 stars, based on 1 article reviews
    non-silencing control (shctrl, target sequence 5’–ttctccgaacgtgtcacgt–3) - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    Inhibiting NTRs in MB cells affects the in vitro sphere‐forming ability and in vivo tumorigenic capacity. A,B) Extreme limiting dilution assays (ELDAs) were conducted to assess the ability of cells to form colonies, demonstrating a decrease in neurosphere frequency upon NTR inhibition in Group 3 (HTB‐187) or Group 3/4 (HTB‐185) cells. HTB‐185 and HTB‐187 cells were seeded in 24‐well ultra‐low attachment plates at various concentrations, including 100, 50, 25, 10, and 5 cells per well. Each sphere‐forming well was counted and the dilution ratio was plotted based on the number of diluted cells and the number of sphere‐forming wells. **** P < 0.0001. C) Display of representative spheres derived from Group 3 or Group 3/4 cells expressing either control shRNA (shCtrl), shHTR2C, or shGABRG2. Images of colonies were captured after 1 week of incubation. D,E) Relative HTR2C or GABRG2 expression was measured by qRT‐PCR in shCtrl, shHTR2C, and shGABRG2 Group3/4 cells. Data are shown as the mean ± SEM. ** P < 0.01. F) left, HE staining of the maximum cross‐sectional area of G3/4 intracranial orthotopic xenograft model among each group. G) Statistical results of the percentage of medulloblastoma tumor size divide the whole section. Data are expressed as dots. ** P < 0.01. H) Immunofluorescence staining of GFAP, IBA1, NeuN revealed less GFAP and increased IBA1 signal in shHTR2C and shGABRG2 groups. Shown are representative images from at least three mice with similar results. I,J) Quantification of GFAP and IBA1 of each group described in H. * P < 0.05, ** P < 0.01, **** P < 0.0001. (Scale bars: 50 µm in C, 2 mm in F, 100 µm in H).

    Journal: Advanced Science

    Article Title: Single‐Cell Chromatin Accessibility Analysis Reveals Subgroup‐Specific TF‐NTR Regulatory Circuits in Medulloblastoma

    doi: 10.1002/advs.202309554

    Figure Lengend Snippet: Inhibiting NTRs in MB cells affects the in vitro sphere‐forming ability and in vivo tumorigenic capacity. A,B) Extreme limiting dilution assays (ELDAs) were conducted to assess the ability of cells to form colonies, demonstrating a decrease in neurosphere frequency upon NTR inhibition in Group 3 (HTB‐187) or Group 3/4 (HTB‐185) cells. HTB‐185 and HTB‐187 cells were seeded in 24‐well ultra‐low attachment plates at various concentrations, including 100, 50, 25, 10, and 5 cells per well. Each sphere‐forming well was counted and the dilution ratio was plotted based on the number of diluted cells and the number of sphere‐forming wells. **** P < 0.0001. C) Display of representative spheres derived from Group 3 or Group 3/4 cells expressing either control shRNA (shCtrl), shHTR2C, or shGABRG2. Images of colonies were captured after 1 week of incubation. D,E) Relative HTR2C or GABRG2 expression was measured by qRT‐PCR in shCtrl, shHTR2C, and shGABRG2 Group3/4 cells. Data are shown as the mean ± SEM. ** P < 0.01. F) left, HE staining of the maximum cross‐sectional area of G3/4 intracranial orthotopic xenograft model among each group. G) Statistical results of the percentage of medulloblastoma tumor size divide the whole section. Data are expressed as dots. ** P < 0.01. H) Immunofluorescence staining of GFAP, IBA1, NeuN revealed less GFAP and increased IBA1 signal in shHTR2C and shGABRG2 groups. Shown are representative images from at least three mice with similar results. I,J) Quantification of GFAP and IBA1 of each group described in H. * P < 0.05, ** P < 0.01, **** P < 0.0001. (Scale bars: 50 µm in C, 2 mm in F, 100 µm in H).

    Article Snippet: Subsequently, 1 × 10 6 shHTR2C, shGABRG2, and shCtrl Group 3/4 cells in 2 μl PBS were carefully injected into the cerebellum of 6–8week‐old female nude mice (BABL/c, Gempharmatech Co., Ltd, China) at the coordinates 2 mm lateral to midline and 1 mm posterior to lambda.

    Techniques: In Vitro, In Vivo, Inhibition, Derivative Assay, Expressing, Control, shRNA, Incubation, Quantitative RT-PCR, Staining, Immunofluorescence

    Downregulation of Beclin-1 enhances apoptosis and reduces cell viability induced by bortezomib in NB4 cells. Cells were infected with lentiviruses expressing shRNAs (non-targeting control or Beclin-1). Puromycin-resistant cells were pooled after each infection. (A) Cells transfected with the control shRNA and shBeclin-1 were treated with or without bortezomib (20 nM) for 24 h, and the expression levels of cleaved caspase-3, cleaved PARP, Bcl-2, p62 and Beclin-1, and LC3-I to LC3-II conversion were determined by western blotting. (B) Ratio of Bcl-2 and β-actin expression levels. Data are presented as the mean ± standard deviation of three independent repeats. *P<0.05 and **P<0.01. (C) Ratio of LC3-II and β-actin expression levels. Data are presented as the mean ± standard deviation of three independent repeats. **P<0.01. (D) Cells transfected with the control shRNA and shBeclin-1 were treated with bortezomib (20 nM) for 0 and 24 h, and cell viability was assessed using a water-soluble tetrazolium salts-8 assay. Data are presented as the mean ± standard deviation of three independent repeats. ***P<0.001. shRNA/sh, short hairpin RNA; CTRL, control; PARP, poly(ADP-ribose) polymerase.

    Journal: Oncology Letters

    Article Title: Inhibition of autophagy enhances apoptosis induced by bortezomib in AML cells

    doi: 10.3892/ol.2020.12370

    Figure Lengend Snippet: Downregulation of Beclin-1 enhances apoptosis and reduces cell viability induced by bortezomib in NB4 cells. Cells were infected with lentiviruses expressing shRNAs (non-targeting control or Beclin-1). Puromycin-resistant cells were pooled after each infection. (A) Cells transfected with the control shRNA and shBeclin-1 were treated with or without bortezomib (20 nM) for 24 h, and the expression levels of cleaved caspase-3, cleaved PARP, Bcl-2, p62 and Beclin-1, and LC3-I to LC3-II conversion were determined by western blotting. (B) Ratio of Bcl-2 and β-actin expression levels. Data are presented as the mean ± standard deviation of three independent repeats. *P<0.05 and **P<0.01. (C) Ratio of LC3-II and β-actin expression levels. Data are presented as the mean ± standard deviation of three independent repeats. **P<0.01. (D) Cells transfected with the control shRNA and shBeclin-1 were treated with bortezomib (20 nM) for 0 and 24 h, and cell viability was assessed using a water-soluble tetrazolium salts-8 assay. Data are presented as the mean ± standard deviation of three independent repeats. ***P<0.001. shRNA/sh, short hairpin RNA; CTRL, control; PARP, poly(ADP-ribose) polymerase.

    Article Snippet: Lentiviral particles containing short hairpin RNA (shRNA/sh) Beclin-1 (cat. no. 131209BZ; 5′-CCGACTTGTTCCTTACGGAAA-3′) and shRNA negative control (shCTRL; cat. no. 131127CZ; 5′-TTCTCCGAACGTGTCACGTTTC-3′) expression vectors were obtained from Shanghai GenePharma Co., Ltd., and were then cloned into pGLV3/H1/GFP-Puro vector (Shanghai GenePharma Co., Ltd.).

    Techniques: Infection, Expressing, Transfection, shRNA, Western Blot, Standard Deviation